Medtronic closed its acquisition of Titan Spine, an interbody implant and surface technology company, ahead of the previously-announced July deadline.
Adding Titan Spine’s product portfolio to Medtronic’s spine technologies expands opportunities to bundle interbodies, screws, rods, biologics and enabling technologies like imaging and navigation to develop integrated procedural offerings. The transaction is expected to be immaterial to Medtronic’s fiscal 2020 adjusted earnings per share, and is expected to meet Medtronic’s long-term financial metrics for acquisitions.
Medtronic closed its acquisition of Titan Spine, an interbody implant and surface technology company, ahead of the previously-announced July deadline.
Adding Titan Spine’s product portfolio to Medtronic’s spine technologies expands opportunities to bundle interbodies, screws, rods, biologics and enabling technologies like imaging and navigation...
Medtronic closed its acquisition of Titan Spine, an interbody implant and surface technology company, ahead of the previously-announced July deadline.
Adding Titan Spine’s product portfolio to Medtronic’s spine technologies expands opportunities to bundle interbodies, screws, rods, biologics and enabling technologies like imaging and navigation to develop integrated procedural offerings. The transaction is expected to be immaterial to Medtronic’s fiscal 2020 adjusted earnings per share, and is expected to meet Medtronic’s long-term financial metrics for acquisitions.
Copy to clipboard 
